Hightower is conducting a non-interventional NSCLC biorepository study in Oklahoma City, OK, using longitudinal blood collection. The study collects clinical and molecular data from NSCLC patients throughout their standard treatment and monitoring. Blood samples are taken over time to track disease progression and explore how changes in ctDNA can help predict recurrence and treatment outcomes. Participation is free, with no insurance required. The study doctor will guide participants through the process and answer any questions to help them make an informed decision.
